AG˹ٷ

STOCK TITAN

[Form 4] Addus HomeCare Corp. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On June 18, 2025, Director Susan T. Weaver reported the acquisition of 1,172 restricted shares of Addus HomeCare Corp. (ADUS) common stock, coded “A� on Form 4, indicating an award or grant from the issuer with no cash consideration ($0 price). The shares will vest in full on June 18, 2026. Following the grant, Weaver’s direct beneficial ownership rises to 12,295 shares. No shares were sold, and no derivative securities were involved. The filing was signed on June 20, 2025 by Attorney-in-Fact Brian Poff.

Il 18 giugno 2025, la Direttrice Susan T. Weaver ha comunicato l'acquisizione di 1.172 azioni vincolate del capitale sociale ordinario di Addus HomeCare Corp. (ADUS), classificate come “A� nel Modulo 4, a indicare un premio o una concessione da parte dell'emittente senza alcun corrispettivo in denaro (prezzo di $0). Le azioni matureranno completamente il 18 giugno 2026. Dopo la concessione, la proprietà diretta effettiva di Weaver sale a 12.295 azioni. Non sono state vendute azioni né coinvolti strumenti derivati. Il documento è stato firmato il 20 giugno 2025 dall’Avvocato delegato Brian Poff.

El 18 de junio de 2025, la Directora Susan T. Weaver informó la adquisición de 1,172 acciones restringidas del capital común de Addus HomeCare Corp. (ADUS), codificadas como “A� en el Formulario 4, lo que indica una concesión o premio por parte del emisor sin contraprestación en efectivo (precio de $0). Las acciones se consolidarán completamente el 18 de junio de 2026. Tras la concesión, la propiedad directa beneficiaria de Weaver aumenta a 12,295 acciones. No se vendieron acciones ni se involucraron valores derivados. El documento fue firmado el 20 de junio de 2025 por el Apoderado Brian Poff.

2025� 6� 18�, 이사 Susan T. WeaverAddus HomeCare Corp. (ADUS) 보통� 1,172� 제한 주식� 취득했다� 보고했습니다. 이 Form 4에서 “A”로 분류되었으며, 발행자로부� 현금 대가 없이 수여� 상여 또 부여임� 나타냅니�(가� $0). 해당 주식읶 2026� 6� 18일에 전액 취득됩니�. 부� � Weaver� 직접 실소� 지�12,295�� 증가했습니다. 주식 매도� 파생상품 거래� 없었습니�. � 문서� 2025� 6� 20�� 법정대리인 Brian Poff가 서명했습니다.

Le 18 juin 2025, la Directrice Susan T. Weaver a déclaré l'acquisition de 1 172 actions restreintes d'actions ordinaires de Addus HomeCare Corp. (ADUS), codées « A » dans le formulaire 4, indiquant une attribution ou une subvention de l'émetteur sans contrepartie monétaire (prix de 0 $). Les actions seront entièrement acquises le 18 juin 2026. Après cette attribution, la possession directe effective de Weaver passe à 12 295 actions. Aucune action n'a été vendue et aucun instrument dérivé n'a été impliqué. Le dépôt a été signé le 20 juin 2025 par le mandataire Brian Poff.

Am 18. Juni 2025 meldete Direktorin Susan T. Weaver den Erwerb von 1.172 eingeschränkten Aktien der Stammaktien von Addus HomeCare Corp. (ADUS), codiert als „A� im Formular 4, was auf eine Zuteilung oder Gewährung durch den Emittenten ohne Barzahlung (Preis $0) hinweist. Die Aktien werden am 18. Juni 2026 vollständig freigegeben. Nach der Zuteilung steigt Weavers direkter wirtschaftlicher Eigentumsanteil auf 12.295 Aktien. Es wurden keine Aktien verkauft und keine Derivate verwendet. Die Einreichung wurde am 20. Juni 2025 vom Bevollmächtigten Brian Poff unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor insider stock grant; neutral market impact.

The transaction adds a small 1,172-share award to a director’s holdings, bringing total ownership to 12,295 shares. Because it is a routine, no-cost equity grant that does not involve open-market buying or selling, it conveys neither bullish nor bearish sentiment. The size is immaterial relative to ADUS’s public float, so I classify the market impact as neutral.

TL;DR: Standard non-employee director compensation; governance status quo.

The one-year vesting aligns with typical board compensation plans and supports long-term alignment without creating immediate dilution pressure. No red flags or unusual structures are present, keeping governance risk unchanged. Therefore, the disclosure is not impactful for strategic or compliance considerations.

Il 18 giugno 2025, la Direttrice Susan T. Weaver ha comunicato l'acquisizione di 1.172 azioni vincolate del capitale sociale ordinario di Addus HomeCare Corp. (ADUS), classificate come “A� nel Modulo 4, a indicare un premio o una concessione da parte dell'emittente senza alcun corrispettivo in denaro (prezzo di $0). Le azioni matureranno completamente il 18 giugno 2026. Dopo la concessione, la proprietà diretta effettiva di Weaver sale a 12.295 azioni. Non sono state vendute azioni né coinvolti strumenti derivati. Il documento è stato firmato il 20 giugno 2025 dall’Avvocato delegato Brian Poff.

El 18 de junio de 2025, la Directora Susan T. Weaver informó la adquisición de 1,172 acciones restringidas del capital común de Addus HomeCare Corp. (ADUS), codificadas como “A� en el Formulario 4, lo que indica una concesión o premio por parte del emisor sin contraprestación en efectivo (precio de $0). Las acciones se consolidarán completamente el 18 de junio de 2026. Tras la concesión, la propiedad directa beneficiaria de Weaver aumenta a 12,295 acciones. No se vendieron acciones ni se involucraron valores derivados. El documento fue firmado el 20 de junio de 2025 por el Apoderado Brian Poff.

2025� 6� 18�, 이사 Susan T. WeaverAddus HomeCare Corp. (ADUS) 보통� 1,172� 제한 주식� 취득했다� 보고했습니다. 이 Form 4에서 “A”로 분류되었으며, 발행자로부� 현금 대가 없이 수여� 상여 또 부여임� 나타냅니�(가� $0). 해당 주식읶 2026� 6� 18일에 전액 취득됩니�. 부� � Weaver� 직접 실소� 지�12,295�� 증가했습니다. 주식 매도� 파생상품 거래� 없었습니�. � 문서� 2025� 6� 20�� 법정대리인 Brian Poff가 서명했습니다.

Le 18 juin 2025, la Directrice Susan T. Weaver a déclaré l'acquisition de 1 172 actions restreintes d'actions ordinaires de Addus HomeCare Corp. (ADUS), codées « A » dans le formulaire 4, indiquant une attribution ou une subvention de l'émetteur sans contrepartie monétaire (prix de 0 $). Les actions seront entièrement acquises le 18 juin 2026. Après cette attribution, la possession directe effective de Weaver passe à 12 295 actions. Aucune action n'a été vendue et aucun instrument dérivé n'a été impliqué. Le dépôt a été signé le 20 juin 2025 par le mandataire Brian Poff.

Am 18. Juni 2025 meldete Direktorin Susan T. Weaver den Erwerb von 1.172 eingeschränkten Aktien der Stammaktien von Addus HomeCare Corp. (ADUS), codiert als „A� im Formular 4, was auf eine Zuteilung oder Gewährung durch den Emittenten ohne Barzahlung (Preis $0) hinweist. Die Aktien werden am 18. Juni 2026 vollständig freigegeben. Nach der Zuteilung steigt Weavers direkter wirtschaftlicher Eigentumsanteil auf 12.295 Aktien. Es wurden keine Aktien verkauft und keine Derivate verwendet. Die Einreichung wurde am 20. Juni 2025 vom Bevollmächtigten Brian Poff unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weaver Susan T

(Last) (First) (Middle)
6303 COWBOYS WAY
SUITE 600

(Street)
FRISCO TX 75034

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 A 1,172(1) A $0 12,295 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.
/s/ Brian Poff, Attorney-In-Fact for Susan T. Weaver 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ADUS shares did Susan T. Weaver acquire in the Form 4?

She acquired 1,172 restricted shares of Addus HomeCare common stock.

What transaction code was used in the ADUS Form 4 filing?

The filing shows transaction code "A", indicating an award or grant.

When will the restricted ADUS shares vest?

The shares will vest in full on June 18, 2026.

What is Susan Weaver’s total direct ownership after the grant?

Her direct beneficial ownership increased to 12,295 shares.

Were any ADUS shares sold or disposed of in this Form 4?

No. The filing only reports an acquisition; no sales were disclosed.

When was the Form 4 for ADUS filed?

The Form 4 was signed and filed on June 20, 2025.
Addus Homecare Corp

NASDAQ:ADUS

ADUS Rankings

ADUS Latest News

ADUS Latest SEC Filings

ADUS Stock Data

2.06B
17.93M
2.4%
103.51%
3.37%
Medical Care Facilities
Services-home Health Care Services
United States
FRISCO